Flock, smart-money disclosures made readable

United Therapeutics Corp Del

UTHRNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−200 sh · $105.7K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,061 sh · $563.5K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−40 sh · $21.6K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,016 sh · $546.1K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−920 sh · $491.5K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−199 sh · $105.5K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−824 sh · $442.2K
Filed 9 Oct 2026SEC Form 4view source
ACQUIREDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.1M
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−200 sh · $105.1K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−800 sh · $426.7K
Filed 9 Oct 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show the latest 50

REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−767 sh · $404.0K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−605 sh · $325.9K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−424 sh · $229.2K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−480 sh · $257.0K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−273 sh · $144.0K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−600 sh · $319.2K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+2
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,091 sh · $588.7K
Filed 9 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−485 sh · $268.9K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,098 sh · $1.1M
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−387 sh · $212.1K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−874 sh · $480.8K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−930 sh · $516.9K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−176 sh · $95.5K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−400 sh · $222.6K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−486 sh · $267.8K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−185 sh · $102.4K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−629 sh · $344.0K
Filed 8 Oct 2026SEC Form 4view source
ACQUIREDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.1M
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,173 sh · $644.1K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−493 sh · $269.1K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−744 sh · $404.6K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−440 sh · $243.0K
Filed 8 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−2,054 sh · $1.1M
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,606 sh · $866.7K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−323 sh · $173.2K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−240 sh · $127.2K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−380 sh · $205.8K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−734 sh · $393.2K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−360 sh · $190.3K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−558 sh · $303.5K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−280 sh · $147.8K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−1,088 sh · $586.0K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−133 sh · $71.5K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−120 sh · $65.1K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−80 sh · $43.6K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−167 sh · $89.2K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−215 sh · $114.6K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−842 sh · $458.7K
Filed 7 Oct 2026SEC Form 4view source
REDUCEDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
−320 sh · $170.2K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Rothblatt Martine A
United Therapeutics Corp Del · NASDAQ
+9,500 sh · $1.1M
Filed 7 Oct 2026SEC Form 4view source